TrialDiabetes, obesity & metabolism2021

A randomized, placebo-controlled study to evaluate the efficacy and safety of adding omarigliptin to insulin therapy in Japanese patients with type 2 diabetes and inadequate glycaemic control.

Takashi Kadowaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.